among which Pervasive Developmental Disorder (Autism Spectrum Disorder) and Regulation Disorder (no other definition) Different developmental disorders
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - age child 12-48 months For patiënts: - Participation in parent-child intervention program for at least 8 weeks, with a minimal attendance of 6 weeks. This inclusion criterium is formulated for inclusion in the final study sample, but has no consequences for the patients' participation to the intervention program.
Exclusion criteria
Exclusion criteria: For control group: - psychiatric problems or need for psychological help in parent or child
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Parent-child interaction, coded with the Dyadic Parent-Child Interaction Coding System (DPICS-III; Eyberg, Nelson, Duke & Boggs, 2005) - Parental self-efficacy, assessed with the Self-Efficacy for Parenting Tasks Index-Toddler Scale (SEPTI-TS; Coleman & Karraker, 2003) and the subscale Parental Competence of the Nijmeegse Ouderlijke Stress Index (NOSI; de Brock, Vermulst, Gerris & Abidin, 1992). - Child temperament, assessed with the Early Child Behaviour Questionnaire (ECBL; Putman, Gartstein & Rothbart, 2006) for toddlers in the age of 12 to 36 months, and the Children*s Behavior Questionnaire (CBQ; Rothbart, Ahadi, Hershey & Fisher, 2001), for toddlers above 36 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Biographical variables; child: date of birth, gender, number of siblings and their date of birth; parent: date of birth, education, occupation, marital status, (former) need for psychiatric/psychological help, (former) psychiatric/psychological treatment, living situation, (former) need for help concerning parenting. - Psychic complaints of parents, assessed with the Symptom Checklist-90-Revised (SCL-90-R; Derogatis, 1994). - Emotional and behavioral problems of the child, measured with the Child Behavior Checklist (CBCL/1*-5 , Achenbach & Rescorla, 2000). The questionnaire will be assessed in the clinical group as part of standard procedures during intake; scores will be derived from the medical files. In the control group the CBCL/1*-5 will be assessed. | — |
Countries
Netherlands